Evidence map›Paper›PMID 39829076›Full record

ArticleJournal of applied physiology (Bethesda, Md. : 1985)2025

Improving glycemic control via heat therapy in older adults at risk for Alzheimer's disease (FIGHT-AD): a pilot study.

Anneka E Blankenship, Riley Kemna, Paul J Kueck, Casey John, Michelle Vitztum, Lauren Yoksh, Jonathan D Mahnken, Eric D Vidoni, Jill K Morris, Paige C Geiger

Abstract read
In one paragraph

Article in Journal of applied physiology (Bethesda, Md. : 1985), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Diabetes, Protein Misfolding, and Heat Stress: Molecular Insights and Translational Perspectives.TH open : companion journal to thrombosis and haemostasis · 2026
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anneka E BlankenshipUniversity of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Fairway, Kansas, United States.ORCID 0009-0006-6181-8035
Riley KemnaUniversity of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Fairway, Kansas, United States.
Paul J KueckUniversity of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Fairway, Kansas, United States.
Casey JohnUniversity of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Fairway, Kansas, United States.
Michelle VitztumKU Diabetes Institute, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States.
Lauren YokshDepartment of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, Kansas, United States.
Jonathan D MahnkenUniversity of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Fairway, Kansas, United States.
Eric D VidoniUniversity of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Fairway, Kansas, United States.ORCID 0000-0001-5181-7131
Jill K MorrisUniversity of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Fairway, Kansas, United States.
Paige C GeigerUniversity of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Fairway, Kansas, United States.ORCID 0000-0002-3990-7246

Funding

University of Kansas Alzheimer's Disease Research Center (KU ADRC)P30AG072973 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Mohammad Haeri · 2021 to 2026
$25.3M
Feasibility of Improving Glycemia to Prevent Alzheimer's DiseaseR01AG081304 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Paige C Geiger, Jill Kathleen Morris · 2023 to 2026
$1.9M
NIA NIH HHS P30 AG072973NIA NIH HHS R01 AG081304
6 · The paper itself

Abstract

Impaired glycemic control increases the risk of type 2 diabetes (T2D) and Alzheimer's disease (AD). Heat therapy (HT), via hot water immersion (HWI), has shown promise in improving shared mechanisms implicated in both T2D and AD, like blood glucose regulation, insulin sensitivity, and inflammation. The potential for HT to improve brain health in individuals at risk for AD has not been examined. This pilot study aimed to assess the feasibility and adherence of using HT in cognitively healthy older individuals at risk for AD due to existing metabolic risk factors. Participants underwent 4 wk of HT (three sessions/week) via HWI, alongside cognitive screening, self-reported sleep characterization, glucose tolerance tests, and MRI scans pre- and postintervention. A total of 18 participants (9 males, 9 females; mean age: 71.1 ± 3.9 yr), demonstrating metabolic risk, completed the intervention. Participant adherence for the study was 96% (8 missed sessions out of 216 total sessions), with one study-related mild adverse event (mild dizziness/nausea). Overall, the research participants responded to a postintervention survey saying they enjoyed participating in the study and it was not a burden on their schedules. Secondary outcomes of the HT intervention demonstrated significant changes in mean arterial pressure, diastolic blood pressure, and cerebral blood flow (

Indexed as

Alzheimer DiseaseBlood GlucoseGlycemic ControlHyperthermia, InducedAgedAged, 80 and overBrainDiabetes Mellitus, Type 2FemaleHot TemperatureHumansMalePilot ProjectsRisk FactorsBlood GlucoseAlzheimer’s diseaseglucose metabolismheat therapyhot water immersionmetabolic dysfunction

Identifiers

PMID39829076
PMCPMC12439486

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.